0606B |
Cocaine and Metabolites Screen, Blood |
0606FL |
Cocaine and Metabolites Screen, Fluid |
0606SP |
Cocaine and Metabolites Screen, Serum/Plasma |
0606U |
Cocaine and Metabolites Screen, Urine |
0930B |
Caffeine, Blood |
0930FL |
Caffeine, Fluid |
0930SP |
Caffeine, Serum/Plasma |
0930U |
Caffeine, Urine |
1300B |
Cocaine and Metabolites, Blood |
1300FL |
Cocaine and Metabolites, Fluid |
1300ME |
Cocaine and Metabolites (Qualitative), Meconium |
1300SP |
Cocaine and Metabolites, Serum/Plasma |
1300TI |
Cocaine and Metabolites, Tissue |
1300U |
Cocaine and Metabolites, Urine |
1303B |
Cocaine and Products Panel, Blood |
1303SP |
Cocaine and Products Panel, Serum/Plasma |
1303U |
Cocaine and Products Panel, Urine |
1390B |
Cyclizine, Blood |
1407B |
Cyclohexane, Blood |
1409B |
Cyclohexanone, Blood |
1409SP |
Cyclohexanone, Serum/Plasma |
1409U |
Cyclohexanone, Urine |
1410U |
Cyclohexanol, Urine |
6920H |
Cocaine and Metabolites Screen, Hair |
8893OF |
Cocaine and Metabolites (Qualitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |